ALDX
Aldeyra Therapeutics, Inc.Company with tickers: ALDX
Market Cap
$114.61M
Shares Outstanding
60,321,068
CIK
1341235
CUSIP
01438T106
13F Activity (30d)
4 filings
3 filers
Website
Visit website
Investor Relations
Investor relations
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Darlene Deptula-Hicks | Chair of the audit committee of the Board | Appointed | 2026-06-10 |
| Darlene Deptula-Hicks | Class III director | Appointed | 2026-06-10 |